The Global Health Observatory

Explore a world of health data

Table Table
Indicator name:
HIV – Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Data type:
Count
Indicator Id:
2936
Topic:
HIV
ISO Health Indicators Framework
Accessibility
Rationale:
The risk for vertical transmission can be reduced significantly by the complementary approaches of providing antiretroviral drugs (as therapy or as prophylaxis) to the mother and antiretroviral prophylaxis to the infant and using safe delivery practices and safer infant feeding. The data will be used to track progress toward global and national goals towards elimination of mother-to-child transmission; to inform policy and strategic planning; for advocacy; and leveraging resources for accelerated scale up.
Definition:
Number of pregnant women living with HIV who received antiretroviral drugs during the past 12 months to reduce mother-to-child transmission.
Disaggregation:
Treatment status at time of pregnancy (already receiving or initiated during pregnancy).
Method of estimation:
National programme records are used to determine the number of pregnant women living with HIV who are receiving ARV.
Method of estimation of global and regional aggregates:
Regional estimates are calculated as the sum of country level data in each of the WHO regions.
Preferred data sources:
National programme records aggregated from programme monitoring tools, such as patient registers and summary reporting forms
Expected frequency of data dissemination:
Annual
Expected frequency of data collection:
Annual
Comments:
Global reports summarizing the coverage of antiretroviral medicine for preventing vertical transmission will exclude women who received single-dose nevirapine, since it is considered a suboptimal regimen.
Contact person email:
beusenbergm@who.int
Name:
Michel Beusenberg
IMRID:
2936
Links:
HIV data and statistics, Global HIV, Hepatitis and STIs Programmes (HHS), Geneva: World Health Organization 
HIV country profiles, Global HIV, Hepatitis and STIs Programmes (HHS), Geneva: World Health Organization 
Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022 
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach: Geneva: World Health Organization; 2021
2023 UNAIDS Global AIDS Update. Geneva: UNAIDS; 2023 
Global AIDS Monitoring 2023: Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS. Geneva: UNAIDS; 2023
UNAIDS epidemiological estimates
Spectrum software, Avenir Health 
UNAIDS HIV tools 
Indicator Metadata Registry List
Globally, there were 1.1 million [910 000–1.3 million] pregnant women with HIV in 2024, of which an estimated 940 000 received antiretroviral drugs to prevent mother-to-child transmission.
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.